Group One Trading
PRME icon

Group One Trading’s Prime Medicine PRME Stock Holding History

Group One Trading’s Portfolio PRME Stock Details PRME Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$92.1K Buy
+30,163
New +$100K ﹤0.01% 4774
2026
Q2 		– Sell
-24,766
Closed -$82.2K – 8294
2026
Q1 		$86.2K Sell
24,766
-78,447
-76% -$299K ﹤0.01% 4861
2025
Q4 		$358K Buy
+103,213
New +$459K ﹤0.01% 3848
2024
Q3 		– Sell
-1,975
Closed -$9.15K – 7214
2024
Q2 		$10.2K Buy
+1,975
New +$12K ﹤0.01% 5637

Other funds holding PRME

Alphabet Inc
Alphabet Inc Mountain View, California $88.3B AUM 46.07% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $174B AUM 33.96% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
Alessandra Capital Management
Alessandra Capital Management Torrance, California $142M AUM 42.73% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $420B AUM 34.97% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $500B AUM 36.84% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $114B AUM 33.83% 1-Year Est. Return

Group One Trading's PRME Position: Q3 2026 in Review

Group One Trading opened a new position in Prime Medicine (PRME) in Q3 2026: 30,163 shares worth $92.1K. The stake represents ﹤0.01% of the portfolio and ranks #4774 among its holdings. This is a return to the name: Group One Trading previously reported a position in PRME as recently as Q1 2026.

Group One Trading first reported a position in PRME in Q2 2024 and has held it in 4 quarters since. The position peaked at $358K in Q4 2025. 76 funds tracked by Wall St. Rank hold PRME as of Q3 2026.

  • Group One Trading held 30,163 shares of Prime Medicine worth $92.1K as of Q3 2026.
  • Prime Medicine was a new Group One Trading position in Q3 2026.
  • Prime Medicine made up ﹤0.01% of Group One Trading's portfolio in Q3 2026, its #4774 holding.
  • Group One Trading first reported a position in Prime Medicine in Q2 2024 and has held it in 4 quarters since.
  • Group One Trading's Prime Medicine position peaked at $358K in Q4 2025.
  • 76 funds tracked by Wall St. Rank held Prime Medicine as of Q3 2026.

Based on Group One Trading's 13F filing for Q3 2026, filed 10 Nov 2026.